Clinical Trials Logo

Clinical Trial Summary

Ocular toxoplasmosis is the most common cause of infectious uveitis worldwide. The diagnosis of ocular toxoplasmosis is primarily clinical when it is a typical presentation .With an atypical presentation in the fundus, parasitological diagnosis is a decisive contribution, as well as multimodal imaging. We investigate on vitreal, retinal, and choroidal morphologic changes in active and scarred toxoplasmosis lesions using swept source optical coherence tomography.


Clinical Trial Description

A retrospective analysis of patients diagnosed with ocular toxoplasmosis was conducted. The patients were examined at ophthalmology service of Farhat Hached Hospital in Sousse Tunisia between January 2002 and December 2017. Complete ophthalmologic examination and OCT were done at the initial visit and during follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04219176
Study type Observational
Source Université de Sousse
Contact
Status Completed
Phase
Start date January 23, 2002
Completion date January 2, 2018

See also
  Status Clinical Trial Phase
Completed NCT01449877 - Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis Phase 3
Completed NCT03948750 - Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis